Coeptis Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Coeptis Therapeutics, Inc. reported Increase (Decrease) in Accounts Payable of $193.78 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2022-11-08
- Coeptis Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was $59.41K.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was $23.67K, a 97.44% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was $110.70K, a 41.14% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2021-12-31 was -$1.24M.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2021 was -$1.58M, a 207.02% decline from fiscal 2020.
- Coeptis Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2020 was $1.47M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 7 month | Increase (Decrease) in Accounts Payable 8 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 10 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2022-09-30 | $59.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $83.08K derived: sum of 2 quarters · filed 2022-11-08 | $193.78K 10-Q · filed 2022-11-08 | -$1.04M derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2022-06-30 | $23.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $134.37K 10-Q · filed 2022-08-02 | -$1.10M derived: sum of 3 quarters · filed 2022-08-02 | -$2.56M derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2022-03-31 | $110.70K 10-Q · filed 2022-05-12 | -$1.13M derived: sum of 2 quarters · filed 2022-05-12 | -$2.58M derived: sum of 3 quarters · filed 2022-11-08 | -$1.66M derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$2.69M derived: sum of 2 quarters · filed 2022-11-08 | -$1.77M derived: sum of 3 quarters · filed 2022-11-08 | -$1.58M 10-K · filed 2022-03-11 | |||
| 2021-09-30 | -$1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$528.71K derived: sum of 2 quarters · filed 2022-11-08 | -$340.62K 10-Q · filed 2022-11-08 | -$782.24K derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $925.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $1.11M 10-Q · filed 2022-08-02 | $671.48K derived: sum of 3 quarters · filed 2022-08-02 | ||||
| 2021-03-31 | $188.09K 10-Q · filed 2022-05-12 | -$253.53K derived: sum of 2 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | -$441.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$1.81K 10-KT · filed 2021-05-11 | $1.47M 10-K · filed 2022-03-11 | ||||
| 2020-11-30 | $4.78K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-01-11 | $2.96K 10-Q · filed 2021-01-11 | |||||
| 2020-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.89M derived: sum of 2 quarters · filed 2021-11-15 | $1.92M 10-Q · filed 2021-11-15 | ||||
| 2020-08-31 | -$1.81K 10-Q/A · filed 2020-11-23 | ||||||
| 2020-06-30 | $203.16K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | $232.16K 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | $29.00K 10-Q/A · filed 2021-05-18 | ||||||
| 2019-12-31 | $0.00 10-KT · filed 2021-05-11 | ||||||
| 2019-11-30 | $0.00 10-Q · filed 2021-01-11 |